IHS Chemical Week

Regions :: North America :: U.S.

FDA and European Medicines Agency strengthen collaboration in pharmacovigilance

5:12 AM MST | February 20, 2014 | Deepti Ramesh

The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA; London) have set-up a new 'cluster' on pharmacovigilance or medicine safety. Clusters are regular collaborative meetings between the EMA and regulators outside of the European Union (EU), which focus on specific topic areas that have been identified as requiring an intensified exchange of information and collaboration. Building on the recent creation of the EMA’s pharmacovigilance risk assessment committee, this cluster will provide a forum for a more systematic and focused...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa